novel
proteinfold
function
rna
recogn
outperform
previous
known
molecular
chaperon
protein
rna
molecular
chaperon
chaperna
activ
intrins
ribozym
oper
viral
infect
purpos
test
whether
influenza
hemagglutinin
ha
assembl
solubl
trimer
immunolog
activ
conform
mean
rna
molecular
chaperon
chaperna
activ
rnainteract
domain
rid
host
immun
select
dock
tag
rna
bind
serv
transduc
chaperna
function
de
novo
fold
trimer
assembl
mutat
affect
trna
bind
greatli
increas
solubl
aggreg
defect
trimer
assembl
suggest
rna
interact
critic
control
kinet
network
foldingassembl
pathway
immun
mice
result
strong
hemagglutin
inhibit
high
titer
neutral
antibodi
provid
steril
protect
lethal
challeng
confirm
immunolog
relev
ha
conform
result
may
translat
rapid
respons
new
influenza
pandem
har
novel
chaperna
describ
herein
immunolog
tailor
antigenfold
function
serv
robust
prophylact
diagnost
tool
viral
infectionsyang
molecular
chaperon
involv
facilit
protein
fold
prevent
protein
aggreg
would
otherwis
lead
cytotox
consequ
convent
pivot
function
consid
uniqu
properti
chaperon
chaperonin
protein
nonetheless
recent
report
suggest
rna
molecul
also
function
chaperon
extrem
effect
execut
fold
varieti
protein
vivo
vitro
potenti
role
rna
modul
aggreg
amyloid
format
report
tumor
suppressor
moreov
chaperon
activ
discov
intrins
ribozym
rna
molecul
function
catalyst
rna
ribozym
respons
matur
trna
larg
rrna
function
peptidyl
transferas
ribosomedepend
protein
synthesi
distinct
rna
chaperon
protein
facilit
structur
alter
rna
molecul
term
rna
molecular
chaperon
chaperna
refer
rna
molecul
serv
chaperon
fold
client
protein
nevertheless
neither
extent
involv
fold
homeostasi
normal
cellular
protein
efficaci
fold
difficulttoexpress
protein
explor
noteworthi
proper
use
molecular
chaperon
vivo
fold
recombin
protein
escherichia
coli
report
isol
case
studi
consider
size
shown
broad
efficaci
conduct
therefor
possibl
moonlight
activ
rna
chaperon
beyond
known
canon
cellular
function
could
use
effici
vehicl
fold
assembl
protein
requir
dedic
explor
respect
recombin
vaccin
assembl
monomer
antigen
oligomer
structur
crucial
import
ligat
b
cell
receptor
enhanc
immunogen
induc
relev
neutral
nt
antibodi
respons
toward
protect
present
studi
show
chaperna
remark
effect
fold
trimer
assembl
influenza
hemagglutinin
ha
immunolog
activ
conform
conveni
avenu
har
chaperon
function
fuse
genet
target
protein
interest
rnainteract
domain
rid
dock
tag
enabl
interact
cellular
rna
judici
choic
rid
requir
biomolecul
function
chaperon
without
physic
interf
oligomer
structur
target
antigen
therefor
rid
prefer
small
suffici
flexibl
interfer
multimer
assembl
target
antigen
moreov
intrins
nonimmunogen
studi
small
trnabind
domain
lysyltrna
synthetas
lysr
aa
posit
deriv
host
immun
select
transduc
chaperna
function
cellular
rna
ntermin
domain
intrins
disord
switch
unfold
structur
ahel
conform
vitro
trna
bind
domain
shown
interact
vitro
nonspecif
trna
exploit
chaperna
function
herein
demonstr
first
time
knowledg
influenza
ha
assembl
solubl
trimer
immunolog
relev
conform
influenza
ha
globular
domain
hagd
includ
host
receptorbind
domain
produc
predominantli
trimer
form
remark
mutat
affect
trnabind
domain
render
trimer
assembl
defect
immun
mice
purifi
ha
elicit
high
degre
hemagglutin
inhibit
hi
high
titer
nt
antibodi
without
crossreact
selfrid
provid
steril
protect
lethal
challeng
pandem
annual
influenza
epidem
caus
consider
mortal
heavi
burden
human
health
speedi
time
deliveri
vaccin
crucial
effect
respons
pandem
convent
system
reli
viru
cultur
either
embryon
egg
cell
cultur
like
meet
time
requir
take
advantag
novel
concept
protein
fold
present
herein
facilit
develop
pandem
vaccin
rna
virus
respons
emerg
reemerg
viral
infect
chaperna
describ
herein
may
offer
novel
prophylact
diagnost
platform
effect
control
manag
infect
basic
differ
rnainteract
domainsrid
ntermin
domain
lysr
lysn
lysrswer
use
construct
express
vector
ntermin
appendag
aa
long
human
lysr
known
interact
nonspecif
trna
vitro
serv
rid
human
origin
hrid
comparison
lysr
e
coli
elysr
kda
lysn
kda
also
use
express
vector
wildtyp
wt
hrid
rnanonbind
mutant
hrid
hridmu
construct
version
first
mutant
aa
substitut
second
mutant
carri
substitut
alanin
third
mutant
contain
substitut
alanin
subsequ
hagd
origin
influenza
apuerto
viru
insert
kpni
hindiii
restrict
site
construct
hridmuhagd
promiscu
gene
express
pge
rid
deriv
vector
serv
express
vector
e
coli
first
lysr
gene
vector
delet
mean
restrict
enzym
ndei
kpni
gene
rid
human
murin
rabbit
origin
amplifi
pcr
result
hrid
mous
rid
mrid
rabbit
rid
rrid
insert
separ
express
cassett
compos
rid
linker
hexaaspart
acid
sequenc
aid
solubl
express
altern
serineglycin
space
linker
tobacco
etch
viru
tev
proteas
recognit
cleavag
site
enlyfq
multipl
clone
site
mc
gtgsdivdkl
kpnibamhiecorvsalihindiii
hexahistidin
tag
nickel
ni
affin
purif
control
promotor
hagd
cdna
strain
amplifi
rtpcr
insert
kpni
hindiii
site
vector
construct
design
yield
fragmentsrid
hagdaft
cleavag
tev
proteas
hrid
serv
templat
mutagenesi
amino
acid
residu
involv
rna
bind
recombin
protein
express
e
coli
strain
star
plyss
invitrogen
carlsbad
ca
usa
purifi
solubl
fraction
cell
lysat
primari
cultur
grown
overnight
ml
luriabertani
medium
contain
mgml
ampicillin
mgml
chloramphenicol
largescal
cultur
implement
ml
luriabertani
medium
inocul
ml
cultur
broth
incub
optic
densiti
nm
od
reach
protein
express
induc
addit
mm
isopropyl
variou
temperatur
cell
harvest
g
od
reach
cell
lysat
obtain
sonic
centrifug
g
min
procedur
separ
supernat
precipit
fraction
protein
purifi
niaffin
chromatographi
solubl
fraction
equilibr
buffer
mm
trishcl
ph
mm
nacl
glycerol
mm
triton
mm
imidazol
appli
ninitrilotriacet
acid
resin
ge
healthcar
littl
chalfont
unit
kingdom
column
preequilibr
buffer
wash
buffer
protein
elut
linear
gradient
imidazol
mm
mean
buffer
b
buffer
supplement
mm
imidazol
fraction
analyz
sdspage
fraction
contain
protein
interest
pool
concentr
centrifug
filter
centriprep
emd
millipor
billerica
usa
dialyz
buffer
c
mm
trishcl
ph
mm
nacl
mm
edta
tween
sdspage
follow
coomassi
stain
concentr
purifi
protein
determin
use
bovin
serum
albumin
bsa
amresco
solon
oh
usa
known
concentr
standard
hagd
without
rid
fusion
form
insolubl
aggreg
necessit
refold
vitro
e
coli
lysat
centrifug
inclus
bodi
wash
triton
pellet
denatur
solubil
guanidin
hydrochlorid
supplement
mm
dtt
final
protein
concentr
mgml
solut
contain
monomer
hagd
dialyz
mm
trishcl
ph
remov
denatur
agent
extent
refold
oligomer
assembl
next
analyz
sizeexclus
chromatographi
sec
predict
potenti
trimer
capac
mridhagd
recombin
protein
crystal
structur
influenza
ha
protein
data
bank
id
ntermin
domain
brugia
malayi
asparaginyltrna
synthetas
protein
data
bank
id
retriev
http
wwwrcsborg
heteroatom
water
molecul
elimin
structur
use
homolog
model
model
http
salilaborg
ridhagd
fusion
version
includ
linker
ddddddsgenlyfq
built
asparaginyltrna
synthetas
structur
serv
templat
mrid
rrid
trimer
mridhagd
rridhagd
structur
confirm
cluspro
proteinprotein
dock
boston
univers
boston
usa
lowest
energi
mridhagd
trimer
kcalmol
rridhagd
trimer
kcalmol
final
structur
visual
mean
surfac
model
univers
california
san
francisco
san
francisco
ca
usa
chimera
softwar
confirm
fold
stabil
effect
rna
solubl
protein
cell
lysat
recombin
protein
mridor
rridhagd
obtain
sonic
bper
lysi
bacteri
protein
extract
reagent
thermo
fisher
scientif
waltham
usa
cell
lysat
centrifug
rpm
min
obtain
solubl
pellet
p
fraction
rnase
mgml
intron
biotechnolog
seongnam
korea
ad
solubl
fraction
incub
min
deplet
fraction
rna
mixtur
st
centrifug
rpm
min
thu
separ
supernat
solubl
fraction
ss
precipit
solubl
fraction
sp
fraction
solubl
fraction
without
rnase
serv
control
fraction
obtain
identifi
sdspage
analysi
gel
oligomer
statu
purifi
recombin
protein
analyz
sec
analyt
gelfiltr
column
ge
healthcar
column
equilibr
buffer
mm
trishcl
ph
mm
nacl
mm
triton
calibr
use
broadrang
mw
marker
ferritin
kda
aldolas
kda
conalbumin
kda
ovalbumin
kda
blue
dextran
kda
ge
healthcar
assay
ml
fetuin
sigmaaldrich
st
loui
mo
usa
per
well
mgml
use
coat
nunc
plate
thermo
fisher
scientif
incub
overnight
plate
wash
pb
contain
mm
trishcl
ph
tween
pbst
block
bsa
pbst
h
room
temperatur
next
ml
recombin
hagd
protein
variou
concentr
ad
well
plate
incub
h
room
temperatur
follow
wash
pbst
recombin
enhanc
green
fluoresc
protein
egfp
rid
serv
control
protein
ml
tag
antibodi
conjug
horseradish
peroxidas
hrp
thermo
fisher
scientif
ad
well
dilut
incub
h
room
temperatur
wash
pbst
ml
hrp
substrat
solut
bd
bioscienc
san
jose
ca
usa
ad
well
plate
develop
dark
min
colorimetr
reaction
blue
yellow
stop
addit
mlwell
n
h
od
measur
micropl
reader
fluostar
optima
bmg
labtech
ortenberg
germani
anim
experi
carri
strict
accord
recommend
korean
food
drug
administr
immun
rabbit
conduct
anim
facil
youngin
frontier
gasandong
south
korea
name
mg
rrid
fusion
protein
emulsifi
freund
complet
adjuv
inject
intraderm
multipl
site
back
rabbit
start
wk
first
immun
anim
boost
twice
proteinadjuv
mixtur
everi
wk
rabbit
blood
collect
wk
boost
centrifug
prepar
serum
store
experiment
protocol
review
approv
institut
anim
care
use
committe
iacuc
youngin
frontier
mous
experi
carri
femal
balbc
mice
orient
bio
seongnam
south
korea
everi
group
mice
immun
via
intraperiton
rout
mg
purifi
ridfus
recombin
protein
hagd
without
rid
along
mg
imject
alum
adjuv
thermo
fisher
scientif
primari
first
boost
second
boost
first
immun
mous
boost
twice
wk
apart
pbsimmun
mice
serv
control
blood
sampl
collect
via
transorbit
bleed
boost
serum
prepar
aliquot
store
protocol
experi
evalu
approv
iacuc
yonsei
laboratori
anim
research
center
two
week
secondari
immun
mice
challeng
intranas
time
ld
ie
plaqueform
unit
pfu
viru
anesthesia
avertin
mock
infect
pb
control
surviv
rate
chang
weight
challeng
mice
measur
everi
day
wk
viru
challeng
mous
blood
sampl
collect
via
transorbit
bleed
centrifug
min
prepar
serum
sampl
end
nunc
plate
thermo
fisher
scientif
coat
ngwell
rid
ridfus
protein
pfuwel
viru
incub
overnight
plate
wash
pbst
block
bsa
pbst
h
room
temperatur
next
ml
serum
sampl
variou
dilut
ad
well
plate
incub
h
room
temperatur
follow
wash
pbst
one
hundr
microlit
secondari
goat
antirabbit
igg
antibodi
goat
antimous
igg
antibodi
conjug
hrp
sigmaaldrich
ad
well
dilut
incub
h
wash
pbst
ml
substrat
solut
bd
bioscienc
ad
well
plate
develop
dark
min
colorimetr
reaction
blue
yellow
stop
addit
n
h
mlwell
od
measur
micropl
reader
fluostar
optima
bmg
labtech
analysi
carri
mean
final
serum
sampl
immun
rabbit
mice
variou
dilut
serum
use
analysi
antibodi
serum
sampl
secondari
antibodi
goat
antirabbit
igg
mab
goat
antimous
igg
antibodi
conjug
hrp
sigmaaldrich
appli
detect
antibodi
ha
serum
sampl
virusinfect
mice
mg
ridhagd
protein
load
onto
gel
sdspage
follow
western
blot
wb
includ
mous
serum
dilut
protein
gel
blot
transblot
turbo
transfer
apparatu
pvdf
midi
transfer
pack
biorad
laboratori
hercul
ca
usa
pvdf
membran
immedi
transfer
block
skim
milk
trisbuff
salinetween
tbst
incub
gentl
agit
h
room
temperatur
wash
tbst
membran
incub
h
overnight
gentl
agit
ml
primaryantibodi
solut
rabbit
mous
serum
dilut
bsa
tbst
blot
rins
time
tbst
incub
ml
secondaryantibodi
solut
contain
hrpconjug
goat
antimous
igg
antibodi
biorad
laboratori
dilut
hrpconjug
goat
antirabbit
igg
antibodi
biorad
laboratori
dilut
pbst
min
gentl
agit
room
temperatur
membran
wash
tbst
follow
develop
mean
ecl
detect
reagent
biorad
laboratori
min
imag
captur
xray
film
use
develop
fix
solut
darkroom
blood
sampl
collect
mice
transorbit
bleed
allow
clot
room
temperatur
clot
remov
sampl
centrifug
microcentrifug
min
rpm
clarifi
serum
sampl
transfer
steril
microcentrifug
tube
heat
inactiv
min
heatinactiv
serum
sampl
subject
serial
dilut
plate
minimum
essenti
medium
thermo
fisher
scientif
analysi
titer
nt
antibodi
influenza
viru
equal
volum
ml
influenza
viru
pfu
ad
dilut
serum
sampl
mix
plate
contain
viru
serum
sampl
incub
h
mixtur
adsorb
plate
contain
confluent
madindarbi
canin
kidney
cell
agaroverlaid
plate
incub
co
incub
cell
monolay
stain
crystal
violet
postinfect
assay
serum
sampl
dilut
analyz
duplic
assay
perform
least
twice
nt
titer
calcul
dilut
correspond
plaqu
reduct
compar
control
serum
sampl
treat
receptordestroy
enzym
remov
nonspecif
agglutin
inhibitor
heat
h
serum
sampl
subject
serial
dilut
pb
plate
equal
volum
ml
influenza
viru
solut
hemagglutin
unit
ad
dilut
serum
sampl
mix
next
plate
incub
h
equal
volum
chicken
erythrocyt
suspens
ad
incub
h
hi
antibodi
titer
serum
express
reciproc
highest
dilut
sampl
complet
inhibit
hemagglutin
sixweekold
femal
balbc
mice
orient
bio
anesthet
intranas
infect
ml
viru
suspens
euthan
cervic
disloc
minim
suffer
viral
replic
respiratori
tract
measur
lung
whole
lung
excis
viral
titrat
whole
lung
homogen
homogen
pb
centrifug
remov
cell
debri
supernat
transfer
new
tube
store
analysi
schemat
present
express
vector
given
fig
initi
screen
solubl
express
varieti
fusion
vectorspgelysr
test
fig
lysr
compos
lysn
ctermin
domain
deriv
e
coli
fig
lysr
eukaryot
origin
carri
extra
ntermin
domain
rid
absent
e
coli
counterpart
fig
target
antigen
hagd
strain
contain
receptorbind
site
use
fig
rid
ntermin
trnabind
domain
aa
lysr
deriv
specieshuman
mice
rabbitsto
obtain
hrid
mrid
rrid
respect
hridmu
fig
addit
rid
lysn
amino
acid
posit
whole
lysr
mice
rabbit
clone
fusion
partner
solubl
express
hagd
test
protein
fusion
linker
contain
enlyfq
sequenc
sitespecif
cleavag
tev
proteas
need
fig
schemat
diagram
ha
trimer
matur
virion
recombin
ridhagd
fusion
protein
shown
fig
accord
report
solubl
fusion
protein
somewhat
influenc
locat
fusion
tag
ntermin
fusion
mrid
increas
watersolubl
express
compar
ctermin
fusion
supplement
fig
addit
ntermin
fusion
protein
mridhagd
elut
mainli
trimer
form
wherea
ctermin
fusion
protein
hagdmrid
elut
dimer
state
supplement
fig
therefor
fusion
tag
studi
place
ntermin
part
target
protein
express
lower
temperatur
increas
solubl
protein
fig
agreement
find
slow
translat
enhanc
proper
fold
solubl
protein
control
direct
express
gfp
bone
morphogenet
protein
without
fusion
rid
yield
predominantli
precipit
insolubl
aggreg
temperatur
condit
test
fig
initi
screen
lysr
protein
solubl
reveal
elysr
superb
solubl
compar
counterpart
mous
rabbit
origin
fig
parallel
analys
show
rid
speci
produc
predominantli
solubl
form
hrid
mrid
rrid
respect
fig
note
rid
equival
absent
e
coli
lysr
fig
therefor
could
test
thu
rid
human
anim
origin
explor
dock
tag
potenti
solubl
express
target
protein
gfp
hagd
fig
e
shown
fig
unlik
hagd
without
rid
hagd
fusion
rid
vari
origin
express
solubl
protein
good
yield
total
protein
solubl
recombin
protein
greatli
enhanc
compar
direct
express
without
fusion
fig
e
overal
express
fusion
partner
mous
origin
mrid
mlysn
mlysr
higher
express
fusion
partner
rabbit
origin
solubl
level
similar
fig
c
e
f
despit
minor
differ
rid
fusion
show
strongli
increas
total
solubl
yield
respect
protein
signific
differ
lysn
rid
promot
solubl
report
protein
rid
chosen
fusion
tag
rest
experi
rid
small
size
kda
expect
interfer
physic
trimer
assembl
hagd
dock
tag
less
immunogen
lysn
kda
lysr
kda
fig
thu
mridhagd
rridhagd
chosen
immunogen
inocul
mice
rabbit
respect
parallel
egfp
use
report
solubl
fusion
rid
solubl
ratio
fig
protein
purifi
ml
cultur
ni
chromatographi
cell
lysi
centrifug
solubl
fraction
contain
bulk
recombin
protein
load
onto
ni
column
protein
elut
linear
gradient
imidazol
rang
mm
ridhagd
protein
tag
purifi
effect
solubl
fraction
sdspage
analysi
reveal
major
protein
band
correspond
expect
molecular
mass
kda
fig
g
ridfus
egfp
tag
also
purifi
abund
solubl
fraction
control
fraction
enrich
ridhagd
fig
ridegfp
fig
pool
concentr
centrifug
filter
quantifi
final
concentr
purifi
protein
mgml
mridhagd
rridhagd
respect
final
concentr
purifi
ridegfp
mgml
mridegfp
rridegfp
respect
likewis
final
concentr
protein
without
fusion
mrid
chemic
refold
mgml
hagd
egfp
respect
recombin
protein
dialyz
pb
oligomer
state
ridfus
protein
hagd
without
rid
determin
sec
increas
column
ge
healthcar
mw
elut
fraction
estim
calibr
marker
protein
known
size
fig
base
elut
volum
partit
coeffici
k
av
mw
mridhagd
estim
kda
likewis
rridhagd
show
elut
volum
ml
estim
size
kda
fig
note
protein
elut
singl
peak
without
peak
void
volum
suggest
protein
predominantli
defin
conform
without
insolubl
aggreg
illdefin
conform
accord
elut
pattern
ridfus
hagd
protein
predominantli
trimer
state
resembl
assembl
statu
whole
ha
protein
influenza
viru
estim
size
trimer
ridhagd
kda
slightli
bigger
calcul
valu
kda
kda
flexibl
natur
fusion
junction
elong
natur
rid
expect
caus
slight
overestim
overal
size
fusion
protein
fig
sdspage
analysi
also
confirm
bulk
ridhagd
protein
present
trimer
fraction
appar
bound
trna
dissoci
fail
copurifi
ha
protein
purif
process
probabl
owe
rel
low
affin
rid
serv
control
mridegfp
elut
elut
volum
ml
indic
mixtur
oligomer
monomer
conform
estim
size
monom
kda
close
calcul
kda
fig
elysrshagd
kda
elut
mixtur
oligomer
dimer
estim
kda
conform
fig
accord
elut
pattern
figur
determin
oligomer
statu
fusion
antigen
gelfiltr
chromatographi
fetuinbind
assay
mridhagd
rridhagd
elut
trimer
form
basi
k
av
follow
analysi
ridhagd
sdspage
mridegfp
control
elut
mixtur
oligomer
monomer
estim
kda
form
b
lysrshagd
control
elut
mixtur
oligomer
dimer
estim
kda
form
c
refold
hagd
without
rid
elut
predominantli
monomer
form
estim
kda
glycoprotein
fetuin
contain
termin
sialic
acid
residu
receptor
ha
adsorb
micropl
analyz
bind
mridhagd
hagd
without
rid
elysrshagd
mridegfp
protein
serv
neg
control
data
obtain
duplic
elysrshagd
protein
mixtur
oligom
dimer
solut
hagd
without
rid
refold
inclus
bodi
kda
elut
mainli
monomer
conform
fig
result
show
efficaci
rid
promot
fold
assembl
report
ha
protein
nativ
trimer
conform
recombin
hagd
protein
evalu
regard
capac
bind
termin
sialic
acid
residu
elisa
trimer
ha
glycoprotein
respons
bind
influenza
viru
sialic
acid
host
cell
membran
initi
infect
cycl
fetuin
glycoprotein
contain
sialic
acid
use
conveni
assay
evalu
bind
function
trimer
assembl
ha
protein
assay
qualiti
ha
fold
could
assess
regard
receptor
bind
initi
stage
viral
infect
result
show
e
colideriv
recombin
ha
glycosyl
bind
fetuin
fig
suggest
glycosyl
import
fold
ha
note
mridhagd
trimer
manifest
stronger
bind
monomer
hagd
without
rid
obtain
refold
fig
elysrshagd
predominantli
dimer
form
fail
bind
case
mridegfp
thu
select
neg
control
fig
consist
report
receptorbind
activ
mridhagd
reflect
proper
fold
assembl
biolog
relev
trimer
conform
effect
rna
solubl
antigen
deplet
rna
rnase
perform
test
potenti
effect
rna
solubl
protein
total
e
coli
lysat
centrifug
prepar
two
fraction
solubl
pellet
p
subsequ
total
solubl
fraction
st
treat
rnase
centrifug
obtain
supernat
solubl
fraction
ss
precipit
solubl
fraction
sp
solubl
protein
greatli
reduc
rnase
treatment
mridhagd
rridhagd
accord
coomassi
stain
fig
result
substanti
semiquantit
protein
band
wb
densitometr
scan
sp
sssp
without
rnase
sssp
rnase
fig
find
show
rna
play
import
role
mainten
solubl
ridfus
ha
protein
address
rna
depend
fold
assembl
mutat
introduc
key
amino
acid
posit
hrid
crucial
involv
trna
bind
choic
mutat
guid
detail
report
mutagenesi
cumul
mutat
lysin
arginin
alanin
introduc
site
gener
three
mutat
site
involv
rna
bind
respect
fig
protein
express
solubl
form
purifi
niaffin
chromatographi
subject
sec
analysi
trimer
assembl
mutant
show
enhanc
solubl
compar
wt
hridhagd
protein
fig
although
solubl
level
notic
differ
protein
purifi
niaffin
chromatographi
fig
remark
sec
data
reveal
number
mutat
increas
proport
trimer
assembl
decreas
correspond
increas
amount
oligom
void
volum
fig
result
strongli
indic
interact
rna
inde
requir
assembl
ha
antigen
immunolog
relev
conform
purifi
protein
appli
antibodi
product
mice
rabbit
immun
ridhagd
ridegfp
fusion
protein
antiserum
obtain
elisa
perform
estim
amount
specif
antibodi
dock
tag
report
protein
respect
fig
elisa
data
confirm
immun
elicit
robust
antibodi
respons
target
report
antigen
hagd
egfp
much
less
toward
rid
dock
tag
first
irrespect
report
protein
elisa
signal
much
stronger
fusion
protein
rid
rrid
fig
b
egfp
hagd
respect
mrid
fig
e
respect
protein
second
report
antigen
elisa
signal
much
stronger
report
antigen
regardless
sourc
dock
protein
compar
fig
hagd
fig
egfp
third
conclus
drawn
regardless
anim
speci
immun
compar
fig
rabbit
fig
f
mice
note
specif
antibodi
respons
report
protein
rel
rid
dock
protein
appreci
differ
regardless
origin
rid
anim
speci
immun
compar
fig
egfp
fig
hagd
probabl
result
high
homolog
amino
acid
sequenc
murin
rabbit
counterpart
contrast
data
elisa
involv
elysrshagd
immunogen
show
similar
magnitud
respons
fusion
protein
elysr
elysrshagd
suggest
immun
respons
direct
predominantli
elysr
dock
tag
neglig
respons
desir
hagd
region
fig
high
immunogen
elysr
may
low
sequenc
homolog
lysr
mous
e
coli
addit
wb
analysi
carri
examin
bind
specif
antibodi
produc
recombin
protein
treatment
tev
proteas
tag
peptid
correspond
mc
expect
remov
rid
ridhagd
fig
accordingli
antibodi
ridhagd
bound
specif
hagd
cleav
ridhagd
remain
uncleav
rid
dock
tag
alon
cleav
fig
f
supplement
fig
fullspectrum
analysi
antibodi
specif
shown
wb
data
supplement
fig
e
rid
fusion
tag
ridegfp
ridhagd
digest
tev
result
cleavag
product
expect
fig
conveni
protein
fragment
without
tag
mc
peptid
moieti
indic
black
white
arrow
respect
rrid
detect
rabbit
antiserum
rais
rrid
fusion
protein
fail
detect
tev
treatment
supplement
fig
result
suggest
posit
detect
albeit
weak
one
wb
result
immun
respons
tag
mc
moieti
rather
selfrrid
dock
tag
determin
whether
antihistidin
tag
antibodi
rais
protein
could
bind
tag
attach
anoth
irrelev
protein
perform
addit
wb
analysi
serum
sampl
rridhagdimmun
rabbit
show
immunoreact
egfp
protein
convers
serum
sampl
mridegfpimmun
mice
show
immunoreact
hagd
protein
supplement
fig
given
tag
common
region
rridhagd
figur
analysi
differ
antibodi
product
level
elisa
wb
differ
antibodi
level
accord
elisa
group
rrid
rridegfp
rel
serum
sampl
rabbit
n
immun
rridegfp
lower
wb
analysi
detect
antibodi
rabbit
serum
sampl
b
differ
antibodi
level
group
rrid
rridhagd
rel
serum
sampl
rabbit
n
immun
rridhagd
lower
wb
analysi
detect
antibodi
rabbit
serum
sampl
cf
differ
antibodi
level
group
rid
ridfus
protein
rel
serum
sampl
mice
n
immun
ridfus
immunogen
lower
wb
analysi
detect
antibodi
mous
serum
sampl
g
differ
antibodi
level
group
elysr
elysrshagd
rel
serum
sampl
mice
n
immun
elysrshagd
error
bar
indic
sd
cohort
xaxi
indic
reciproc
serum
dilut
log
initi
serum
dilut
valu
mice
rabbit
respect
egfp
mridegfp
hagd
like
band
indic
black
arrow
repres
specif
interact
antihi
tag
antibodi
tag
likewis
rridegfp
rridhagd
predomin
respons
direct
egfp
hagd
report
protein
rather
rrid
likewis
mrid
weakli
reactiv
murin
antiserum
mridegfp
supplement
fig
reactiv
disappear
tev
cleavag
white
arrow
suggest
selfmrid
immunogen
mice
lack
crossreact
mous
antiserum
rrid
rabbit
origin
probabl
result
high
homolog
rid
host
speci
supplement
fig
therefor
weak
distinct
elisa
respons
rid
dock
tag
fig
actual
result
immunogen
rid
peptid
artifici
introduc
affin
purif
clone
purpos
find
indic
rid
dock
tag
nonimmunogen
immun
respons
aim
predominantli
desir
viral
antigen
immun
wb
analys
along
elisa
confirm
rid
serv
excel
enhanc
fold
assembl
target
antigen
without
compromis
specif
immun
respons
mice
infect
intranas
subleth
dose
pfu
viru
obtain
antiserum
viru
four
week
later
blood
drawn
mous
via
transorbit
collect
serum
prepar
mice
surviv
maxim
weight
loss
postchalleng
dpc
recov
slowli
furthermor
wk
later
blood
collect
recov
mice
result
serum
subject
elisa
wb
analys
fig
b
supplement
fig
result
confirm
ridhagd
trimer
form
fig
coat
antigen
detect
highli
dilut
antisera
infect
mice
n
wherea
refold
hagd
without
rid
monomer
form
fig
detect
much
lower
dilut
antisera
lower
ridhagd
rid
dock
tag
neg
control
fail
show
figur
detect
antiinfluenza
viru
antibodi
mous
serum
sampl
mean
recombin
viral
protein
viru
b
elisa
wb
data
reveal
recombin
protein
ridhagd
detect
highli
dilut
antibodi
viru
serum
sampl
infect
mice
n
wherea
refold
hagd
without
rid
coat
protein
compar
ridhagd
detect
much
lower
dilut
fold
lower
antisera
rid
dock
tag
fail
show
immunoreact
c
elisa
data
detect
antibodi
serum
sampl
mice
infect
variou
virus
n
coat
antigen
recombin
mridhagd
protein
coldadapt
genet
reassort
carri
intern
gene
coldadapt
viru
surfac
ha
neuraminidas
gene
wt
virus
use
sourc
ha
antigen
nc
new
caledonia
pa
panama
id
indonesia
kr
korea
influenza
b
viru
yamagata
elisa
data
show
accord
number
boost
hightit
antibodi
serum
sampl
mice
n
immun
mridhagd
mgmous
bound
viru
pfuwel
error
bar
indic
sd
cohort
xaxi
indic
reciproc
serum
dilut
log
initi
serum
dilut
valu
e
elisa
data
show
regardless
number
boost
antibodi
serum
sampl
mice
n
immun
hagd
without
rid
mgmous
hardli
bound
viru
pfuwel
error
bar
indic
sd
group
xaxi
indic
reciproc
serum
dilut
log
initi
serum
dilut
immunoreact
fig
b
wb
confirm
antibodi
respons
direct
hagd
wherea
rid
either
tev
cleavag
fail
react
antiserum
supplement
fig
result
indic
recombin
ridhagd
may
serv
diagnost
antigen
high
specif
sensit
influenza
infect
addit
compar
elisa
reactiv
among
variou
antisera
mice
infect
differ
subtyp
influenza
strain
expect
highest
reactiv
seen
homolog
antiserum
fig
potenti
crossreact
differ
ha
antigen
examin
use
coldadapt
reassort
strain
carri
intern
gene
coldadapt
viru
gene
encod
surfac
protein
ha
neuraminidas
wt
virus
lower
reactiv
observ
heterolog
viru
new
caledonia
nc
heterosubtyp
includ
panama
pa
indonesia
id
korea
kr
fig
supplement
fig
altern
test
whether
antibodi
elicit
ridhagd
vaccin
bind
homolog
viru
conduct
elisa
antisera
mice
immun
mridhagd
hagd
without
rid
control
n
mean
viru
coat
antigen
fig
e
result
confirm
mridhagd
elicit
specif
antibodi
homolog
viru
repeat
boost
fusion
protein
amplifi
antibodi
respons
suggest
qualiti
recombin
antigen
immunolog
relev
despit
immun
antisera
hagd
without
rid
rare
bound
virus
indic
hagd
without
rid
could
induc
antibodi
respons
specif
viru
mice
fig
result
suggest
recombin
ridhagd
may
serv
good
antigen
accur
diagnosi
infect
quantif
vaccin
antigen
determin
whether
ridhagd
recombin
protein
suitabl
vaccin
antigen
elicit
protect
antibodi
conduct
hi
assay
nt
assay
use
antisera
deriv
immun
anim
hi
assay
viru
carri
mean
antisera
collect
mice
n
immun
ridhagd
mgmous
ridegfp
control
mgmous
along
alum
adjuv
thermo
fisher
scientif
via
intraperiton
rout
mous
antisera
ridhagd
show
detect
level
hi
titer
nt
antibodi
titer
wherea
ridegfp
group
fail
show
activ
fig
c
hi
activ
appear
similar
regardless
origin
rid
dock
protein
therefor
use
mridhagd
mgmous
hagd
without
rid
mgmous
pb
detail
analys
immun
respons
conduct
primeboost
immun
n
via
intraperiton
rout
fig
e
shown
fig
e
boost
immun
mridhagd
mgmous
augment
immun
respons
high
hi
titer
achiev
second
boost
immun
wherea
nt
antibodi
level
correl
hi
antibodi
level
multipl
immun
hagd
without
rid
gener
hi
nt
antibodi
viru
fig
e
antisera
rabbit
n
immun
mg
rridhagd
recombin
vaccin
fig
g
show
higher
hi
titer
higher
nt
antibodi
level
shown
mous
antisera
fig
c
control
rabbit
antisera
ridegfp
protein
pb
show
neither
hi
abil
nt
titer
homolog
viru
fig
g
result
clearli
show
ridhagd
fusion
protein
could
optim
effect
vaccin
antigen
produc
protect
nt
antibodi
respons
influenza
virus
immun
mice
challeng
intranas
one
time
ld
viru
pfu
anesthesia
surviv
rate
chang
weight
challeng
mice
monitor
daili
mice
immun
intraperiton
mg
ridhagd
antigen
mridhagd
n
rridhagd
n
lost
bodi
weight
dpc
fig
b
altern
immun
mg
mridhagd
n
via
intraperiton
rout
result
loss
bodi
weight
dpc
weight
fulli
recov
thereaft
fig
complet
protect
achiev
vaccin
ridhagd
recombin
antigen
wherea
mice
n
immun
pb
control
die
within
dpc
note
immun
elysrshagd
even
high
dose
mg
even
high
reactiv
elisa
fig
fail
provid
protect
mice
n
succumb
within
dpc
fig
immun
hagd
without
rid
mg
result
less
protect
efficaci
compar
mridhagd
judg
weight
chang
surviv
rate
mice
n
challeng
fig
lung
viral
titer
mridhagdimmun
group
detect
limit
dpc
wherea
persist
viral
infect
detect
pb
control
group
fig
evalu
potenti
crossreact
heterosubtyp
mice
challeng
viru
time
ld
vaccin
immun
mice
die
within
dpc
viral
titer
remain
high
dpc
fig
indic
ridhagd
provid
strainspecif
protect
rapid
weight
loss
homolog
infect
novel
proteinfold
function
rna
molecul
recogn
rna
even
outperform
previous
known
molecular
chaperon
protein
specif
case
initi
recogn
hiv
infect
chaperna
activ
intrins
ribozym
probabl
oper
figur
immunogen
ridhagd
recombin
vaccin
schemat
illustr
immun
challeng
schedul
b
hi
assay
viru
conduct
antisera
collect
mice
n
immun
intraperiton
ridhagd
mgmous
ridegfp
control
mgmous
along
alum
adjuv
c
assay
nt
viru
perform
serum
sampl
mice
n
immun
ridhagd
mg
mous
ridegfp
control
mgmous
detect
limit
hi
assay
nt
assay
respect
hi
assay
toward
viru
perform
serum
sampl
mice
n
immun
intraperiton
mridhagd
mgmous
pb
hagd
without
rid
mgmous
hi
antibodi
titer
increas
depend
number
immun
boost
mridhagd
mgmous
howev
immun
boost
pb
hagd
without
rid
yield
immun
respons
e
assay
nt
viru
perform
serum
sampl
mice
n
immun
mridhagd
mgmous
pb
hagd
without
rid
mgmous
respect
nt
antibodi
titer
increas
factor
depend
number
boost
howev
immun
boost
pb
hagd
without
rid
yield
immun
respons
detect
limit
hi
assay
nt
assay
respect
f
antisera
rabbit
n
immun
mg
rridhagd
recombin
vaccin
show
higher
hi
titer
mous
antisera
b
g
rabbit
antisera
n
obtain
immun
mg
rridhagd
show
higher
titer
nt
antibodi
mous
antisera
c
control
rabbit
antisera
n
immun
mg
ridegfp
protein
show
neither
hi
abil
nt
antibodi
homolog
viru
fold
homeostasi
normal
cellular
protein
whether
chaperna
oper
combin
molecular
chaperon
protein
de
novo
fold
protein
remain
excit
possibl
nonetheless
varieti
guest
protein
amen
rnadepend
fold
yet
known
ident
rna
molecul
among
rnainteract
protein
well
document
conveni
avenu
exploit
mice
immun
intraperiton
mg
ridhagd
n
ridegfp
control
n
along
alum
adjuv
challeng
time
ld
viru
pfu
bodi
weight
chang
surviv
rate
b
infect
mice
monitor
daili
immun
ridegfp
control
n
fail
provid
protect
mice
n
succumb
within
dpc
c
mice
vaccin
intraperiton
mg
mridhagd
immunogen
n
mock
infect
pb
control
n
challeng
time
ld
viru
pfu
bodi
weight
chang
c
surviv
rate
infect
mice
monitor
daili
mice
immun
mg
lysrshagd
n
mg
hagd
without
rid
n
also
challeng
time
ld
viru
pfu
bodi
weight
chang
infect
mice
monitor
daili
c
immun
elysrshagd
pb
fail
provid
protect
mice
n
succumb
within
dpc
immun
hagd
without
rid
provid
partial
protect
one
mous
succumb
within
dpc
e
f
replic
challeng
viru
lung
immun
mice
titer
challeng
viru
lung
measur
viral
plaqu
assay
dash
line
denot
detect
limit
error
bar
indic
sd
cohort
chaperon
activ
rna
fold
difficulttoexpress
protein
use
rid
interact
known
identifi
rna
molecul
fusion
target
protein
take
advantag
chaperna
function
herein
first
time
show
influenza
ha
assembl
solubl
trimer
immunolog
activ
conform
influenza
ha
antigen
could
produc
bacteria
solubl
trimer
structur
induc
product
nt
antibodi
effect
protect
lethal
challeng
reveal
pandem
suppli
suffici
dose
vaccin
within
short
period
prerequisit
mitig
econom
effect
address
public
health
concern
pandem
previous
effort
toward
bacteri
product
recombin
ha
vaccin
depend
chemic
refold
misfold
insolubl
aggreg
process
depend
initi
product
ha
insolubl
aggreg
requir
subsequ
chemic
refold
procedur
involv
solubil
chaotrop
agent
dilut
concentr
immunolog
relev
conform
obtain
therefor
product
immunolog
relev
antigen
mammalian
insect
cell
baculoviru
vector
system
favor
nevertheless
system
invari
requir
cell
cultur
method
highli
expens
difficult
scale
product
ha
solubl
trimer
conform
greatli
simplifi
product
process
ensur
qualiti
result
vaccin
make
amen
implement
pandem
prepared
propos
system
rid
serv
dock
tag
transduc
chaperon
function
rna
fold
assembl
downstream
report
protein
ha
via
interact
resid
cellular
trna
function
perspect
coupl
action
chaperon
protein
fold
assembl
similar
chaperon
protein
result
also
indic
rid
deriv
variou
anim
use
immunolog
tailor
antigenfold
vehicl
antigen
could
serv
diagnost
prophylact
tool
viral
infect
addit
de
novo
fold
monom
subsequ
assembl
monomer
antigen
multimericord
structur
crucial
import
especi
augment
immun
respons
proper
present
epitop
immun
cell
toward
protect
therefor
judici
choic
rid
requir
mediat
chaperna
function
dock
tag
physic
interfer
format
oligomer
structur
present
studi
nterminalappend
trnainteract
domain
eukaryot
lysr
chosen
rid
domain
small
aa
long
belong
famili
intrins
unfold
domain
expect
suffici
flexibl
physic
interfer
trimer
assembl
ha
locat
downstream
intrins
influenza
hagd
protein
express
purifi
predominantli
trimer
fig
although
express
level
solubl
elysrshagd
contain
elysr
altern
trnabind
domain
substanti
higher
fusion
protein
exist
primarili
dimer
confirm
gelfiltr
chromatographi
nativ
condit
fig
possibl
stabil
energi
dimer
rel
larg
lysr
kda
may
physic
interfer
trimer
hagd
kda
therefor
despit
high
immunogen
demonstr
elisa
fig
immun
fail
provid
protect
lethal
challeng
fig
howev
hagd
without
attach
rid
protein
yield
interest
result
administ
mice
even
without
elicit
antibodi
respons
three
immun
hagd
without
rid
partial
protect
mice
lethal
challeng
assum
partial
protect
may
cellmedi
immun
ha
sever
report
indic
exist
cell
epitop
ha
influenza
virus
like
multipl
immun
hagd
without
rid
induc
specif
cell
respons
contribut
protect
result
emphas
import
assembl
antigen
nativ
conform
induct
protect
nt
antibodi
respons
process
distinct
advantag
chemic
refold
insolubl
aggreg
requir
solubil
chaotrop
agent
dilut
concentr
adopt
immunolog
relev
conform
product
hagd
receptorbind
domain
solubl
trimer
immunolog
activ
conform
ensur
qualiti
viral
antigen
make
amen
implement
pandem
prepared
worth
compar
mechanist
differ
process
describ
herein
approach
oligomer
assembl
ha
exist
approach
involv
fusion
ha
ferritin
nanoparticl
foldon
deriv
natur
trimer
domain
isoleucin
zipper
fibritin
wherein
major
amount
stabil
energi
provid
extern
trimer
domain
present
approach
use
chaperna
rid
remain
independ
monom
thu
expect
contribut
intermolecular
stabil
among
hagd
rather
trimer
format
primarili
driven
intrins
stabil
energi
mutual
interact
among
hagd
rid
small
structur
independ
domain
expect
interfer
interact
within
hagd
trimer
space
govern
thermodynam
stabil
energi
assembl
trimer
rid
test
present
studi
deriv
human
lysr
switch
spontan
unfold
structur
ahel
structur
trna
bind
noteworthi
uniqu
abil
intrins
unfold
domain
increas
solubl
target
protein
report
although
effect
biolog
activ
remain
unknown
rid
use
studi
rel
unfold
therefor
link
dock
protein
rid
may
increas
solubl
agreement
report
therefor
intrigu
protein
maintain
high
solubl
even
higher
wt
hrid
fig
yet
extent
trimer
assembl
hagd
greatli
lower
fig
result
confirm
rna
interact
inde
crucial
trimer
assembl
ha
result
also
offer
discretionari
note
qualiti
evalu
recombin
antigen
solubl
necessari
suffici
repres
biolog
immunolog
relev
conform
mechan
chapernamedi
assembl
monom
explor
although
function
similar
proteinbas
molecular
chaperon
molecular
chaperon
proven
crucial
de
novo
fold
also
assembl
monom
multimer
complex
moreov
contrast
foldas
type
molecular
chaperon
consum
atp
recycl
chaperon
dock
protein
chaperna
expect
function
chaperon
without
atp
requir
way
similar
holdas
type
chaperon
affin
rna
may
determin
factor
captur
fold
guest
protein
addit
potenti
effect
trnainduc
ahel
structur
transit
rid
fold
downstream
dock
protein
investig
overal
result
show
rna
affect
kinet
landscap
fold
pathway
favor
product
fold
assembl
vaccin
antigen
potenti
immunogen
rid
dock
tag
taken
account
especi
design
fold
vehicl
vaccin
antigen
ensur
specif
antibodi
respons
direct
hagd
immun
rid
remain
nonimmunogen
accordingli
rid
origin
prefer
host
immun
murin
origin
studi
wherein
immun
mice
mous
model
lethal
challeng
use
human
clinic
trial
rid
human
origin
direct
elicit
antibodi
respons
predominantli
ha
chaperna
function
may
extend
supramolecular
assembl
viral
antigen
requir
augment
immunogen
recent
confirm
present
strategi
success
appli
assembl
bacteri
synthes
monom
noroviru
particl
compris
monom
viruslik
particl
vlp
unpublish
result
howev
vlp
assembl
prior
cleavag
rid
tag
requir
enabl
compact
pack
vlp
system
may
also
appli
prepar
mab
diagnost
therapeut
intervent
basic
process
involv
isol
spleen
cell
immun
mous
follow
fusion
immort
cell
screen
reactiv
clone
case
rid
origin
host
immun
murin
rabbit
origin
studi
use
ensur
posit
antibodi
clone
direct
target
antigen
instanc
spike
protein
middl
east
respiratori
syndrom
coronaviru
unpublish
result
summari
chaperon
function
rna
intrins
natur
occur
ribozym
could
exploit
fold
assembl
viral
antigen
immunolog
relev
conform
process
expect
facilit
time
suppli
pandem
vaccin
shorter
lead
time
well
design
immunolog
tailor
fold
vehicl
repertoir
antigen
prophylact
diagnost
purpos
